10075-24-8 Usage
Uses
Used in Pharmaceutical Industry:
2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine (1:2) may be used as a pharmaceutical compound for [specific application reason], given the presence of the dibenzazepine moiety, which is known to be a structural feature in various types of drugs.
Used in Chemical Industry:
In the chemical industry, 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine (1:2) could be utilized as a chemical intermediate for the synthesis of other complex organic compounds or materials, due to its unique structure and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 10075-24-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,0,7 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 10075-24:
(7*1)+(6*0)+(5*0)+(4*7)+(3*5)+(2*2)+(1*4)=58
58 % 10 = 8
So 10075-24-8 is a valid CAS Registry Number.
10075-24-8Relevant academic research and scientific papers
ABUSE DETERRENT AND ANTI-DOSE DUMPING PHARMACEUTICAL SALTS USEFUL FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER
-
Page/Page column 28, (2012/02/06)
A pharmaceutical composition comprising a drug substance consisting essentially of a pharmaceutically acceptable organic acid addition salt of an amine containing pharmaceutically active compound wherein the amine containing pharmaceutical active compound is selected from the group consisting of racemic or single isomer ritalinic acid or phenethylamine derivatives and the drug substance has a physical form selected from amorphous and polymorphic.
Physical states of a pharmaceutical drug substance
-
, (2010/06/11)
An amorphous form of imipramine pamoate, morphologically pure forms, and mixtures of amorphous and morphologically pure imipramine pamoate characterized by differential scanning calorimetry, fourier transform infrared, and powder x-ray diffraction, and pharmaceutical compositions formed therefrom.
